Holders · period archive

CCCC · C4 Therapeutics Inc.

Q2 2023 13F holders

← latest ownership dossier

Ticker: CCCC
Type: Equity
Class: COM STK
Total reported value ($000, long equity)

Manager	Report date	Value	Shares